Literature DB >> 19506944

Obesity, gut hormones, and bariatric surgery.

Dimitrios J Pournaras1, Carel W le Roux.   

Abstract

Obesity is becoming the healthcare epidemic of this century. Bariatric surgery is the only effective treatment for morbid obesity. Gut hormones are key players in the metabolic mechanisms causing obesity. In this review we explore the role of these hormones as facilitators of appetite control and weight loss after bariatric surgery, and we describe the now established gut-brain axis.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19506944     DOI： 10.1007/s00268-009-0080-9

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


  68 in total

1.  Oxyntomodulin suppresses appetite and reduces food intake in humans.

Authors:  Mark A Cohen; Sandra M Ellis; Carel W Le Roux; Rachel L Batterham; Adrian Park; Michael Patterson; Gary S Frost; Mohammad A Ghatei; Stephen R Bloom
Journal:  J Clin Endocrinol Metab       Date:  2003-10       Impact factor: 5.958

2.  Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty.

Authors:  J M Kellum; J F Kuemmerle; T M O'Dorisio; P Rayford; D Martin; K Engle; L Wolf; H J Sugerman
Journal:  Ann Surg       Date:  1990-06       Impact factor: 12.969

3.  A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans.

Authors:  D E Cummings; J Q Purnell; R S Frayo; K Schmidova; B E Wisse; D S Weigle
Journal:  Diabetes       Date:  2001-08       Impact factor: 9.461

4.  Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake.

Authors:  Jian V Zhang; Pei-Gen Ren; Orna Avsian-Kretchmer; Ching-Wei Luo; Rami Rauch; Cynthia Klein; Aaron J W Hsueh
Journal:  Science       Date:  2005-11-11       Impact factor: 47.728

Review 5.  Lack of obestatin effects on food intake: should obestatin be renamed ghrelin-associated peptide (GAP)?

Authors:  G Gourcerol; D H St-Pierre; Y Taché
Journal:  Regul Pept       Date:  2007-01-12

6.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

7.  Gut hormone PYY(3-36) physiologically inhibits food intake.

Authors:  Rachel L Batterham; Michael A Cowley; Caroline J Small; Herbert Herzog; Mark A Cohen; Catherine L Dakin; Alison M Wren; Audrey E Brynes; Malcolm J Low; Mohammad A Ghatei; Roger D Cone; Stephen R Bloom
Journal:  Nature       Date:  2002-08-08       Impact factor: 49.962

8.  Ghrelin, leptin and insulin levels after restrictive surgery: a 2-year follow-up study.

Authors:  Jeroen Nijhuis; Francois M H van Dielen; Wim A Buurman; Jan Willem M Greve
Journal:  Obes Surg       Date:  2004 Jun-Jul       Impact factor: 4.129

Review 9.  Obesity wars: molecular progress confronts an expanding epidemic.

Authors:  Jeffrey S Flier
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

10.  Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety.

Authors:  C M Borg; C W le Roux; M A Ghatei; S R Bloom; A G Patel; S J B Aylwin
Journal:  Br J Surg       Date:  2006-02       Impact factor: 6.939
View more
  23 in total

1.  Food Intake and Changes in Eating Behavior After Laparoscopic Sleeve Gastrectomy.

Authors:  Ilenia Coluzzi; Luigi Raparelli; Laura Guarnacci; Emanuela Paone; Gianmattia Del Genio; Carel W le Roux; Gianfranco Silecchia
Journal:  Obes Surg       Date:  2016-09       Impact factor: 4.129

Review 2.  Biological effects of bariatric surgery on obesity-related comorbidities.

Authors:  Sabrena F Noria; Teodor Grantcharov
Journal:  Can J Surg       Date:  2013-02       Impact factor: 2.089

3.  Bariatric Surgery and Liver Transplantation.

Authors:  Duminda Suraweera; Elena G Saab; Gina Choi; Sammy Saab
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-03

4.  Liraglutide suppression of caloric intake competes with the intake-promoting effects of a palatable cafeteria diet, but does not impact food or macronutrient selection.

Authors:  Kellie M Hyde; Ginger D Blonde; Carel W le Roux; Alan C Spector
Journal:  Physiol Behav       Date:  2017-03-30

5.  Bariatric surgery in a patient with complete MC4R deficiency.

Authors:  I R Aslan; S A Ranadive; B A Ersoy; S J Rogers; R H Lustig; C Vaisse
Journal:  Int J Obes (Lond)       Date:  2010-08-24       Impact factor: 5.095

Review 6.  The role of bariatric surgery in the treatment of diabetes.

Authors:  Ji Chung Tham; Noah Howes; Carel W le Roux
Journal:  Ther Adv Chronic Dis       Date:  2014-05       Impact factor: 5.091

Review 7.  All bariatric surgeries are not created equal: insights from mechanistic comparisons.

Authors:  Margaret A Stefater; Hilary E Wilson-Pérez; Adam P Chambers; Darleen A Sandoval; Randy J Seeley
Journal:  Endocr Rev       Date:  2012-05-01       Impact factor: 19.871

Review 8.  Regulation of food intake: the gastric X/A-like endocrine cell in the spotlight.

Authors:  Andreas Stengel; Yvette Taché
Journal:  Curr Gastroenterol Rep       Date:  2009-12

9.  Ghrelin and metabolic surgery.

Authors:  Dimitrios J Pournaras; Carel W le Roux
Journal:  Int J Pept       Date:  2010-01-27

10.  Alcohol consumption after laparoscopic sleeve gastrectomy: 1-year results.

Authors:  Ilenia Coluzzi; Angelo Iossa; Elena Spinetti; Gianfranco Silecchia
Journal:  Eat Weight Disord       Date:  2018-02-06       Impact factor: 4.652
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.